Associated Papers
Clinical and Hematological Relevance of JAK2V617F, CALR, and MPL Mutations in Vietnamese Patients with Essential Thrombocythemia.
Vu HA et al.
Asian Pacific Journal of Cancer Prevention : Apjcp, 2019
Detection of CALR Mutations Using High Resolution Melting Curve Analysis (HRM-A); Application on a Large Cohort of Greek ET and MF Patients.
Giannopoulos A et al.
Mediterranean Journal of Hematology and Infectious Diseases, 2019
Three Novel Calreticulin Mutations in Two Turkish Patients.
Hançer VS et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology, 2017
A novel molecular assay using hybridisation probes and melt curve analysis for CALR exon 9 mutation detection in myeloproliferative neoplasms.
Keaney T et al.
Journal of Clinical Pathology, 2017
A new monoclonal antibody (CAL2) detects CALRETICULIN mutations in formalin-fixed and paraffin-embedded bone marrow biopsies.
Stein H et al.
Leukemia, 2016
JAK2 V617F, MPL, and CALR Mutations in Korean Patients with Essential Thrombocythemia and Primary Myelofibrosis.
Kim BH et al.
Journal of Korean Medical Science, 2015
Calreticulin mutations in myeloproliferative neoplasms and new methodology for their detection and monitoring.
Chi J et al.
Annals of Hematology, 2015
Incidence, clinical features, and prognostic impact of CALR exon 9 mutations in essential thrombocythemia and primary myelofibrosis: an experience of a single tertiary hospital in Korea.
Park SH et al.
Annals of Laboratory Medicine, 2015
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.
Nangalia J et al.
The New England Journal of Medicine, 2013
Select a paper to view details